Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Small Cell × belotecan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 2 Uterine Cervical Neoplasms 1 Lung Neoplasms 1 Carcinoma, Small Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 4 Topotecan 3 Etoposide 3 belinostat 2 Pemetrexed 2 Paclitaxel 2 Carboplatin 2 vosaroxin 1 vinflunine 1 veliparib 1 taxane 1 sagopilone 1 pembrolizumab 1 lurtotecan 1 liposomal doxorubicin 1 belotecan 1 Vinorelbine 1 Taxes 1 Sorafenib 1 RRx-001 1 Podophyllotoxin 1 Platinum 1 PT-100 dipeptide 1 Nortriptyline 1 Irinotecan 1 Gemcitabine 1 Fluorouracil 1 BI 2536 1 Arsenic Trioxide 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00826644 2021-08-09

COMBAT

Chonnam National University Hospital

Phase 3 Completed

Carcinoma, Small Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡